|
First Article
Aids Virus
THE AIDS VIRUS
AIDS -- the initials stand for Acquired Immune Deficiency
Syndrome -- was first diagnosed by the Center for Disease
Control in Atlanta, Georgia, in 1981. It is a virus that
immobilizes the victim's immune defense mechanisms, allowing
such opportunistic infections as Kaposi's Sarcoma and
Pneumocystis Carcinii to invade and destroy the patient.
By the end of 1985, there were 14,000 reported cases and no
known cure or vaccine . The virus is transmitted through semen
and/or blood products with the high risk groups including
sexually active gay and bisexual men, intravenous drug abusers,
and their sexual partners (male or female).
A highly significant climate of fear has arisen around this
epidemic - significant for the lives of those infected by the
virus as well as for the lives of our national and world
communities as we struggle to face the ramifications of this
disease. The fear is exemplified by Congressmen asking for the
quarantining (read imprisonment) of AIDS sufferers; by insurance
companies wanting to deny gay and bisexual men health insurance;
by Evangelicals stating that this is God's punishment on an
abominable life style (referring mostly to homosexuals, but also
to drug abusers).
What is this virus that is causing such wide-spread discomfort
to the body and to the psyche? Before answering that question,
let us look at how the body ordinarily protects itself from
disease.
The body's defense mechanism involves a complex and impressive
system of recognition, communication, and action. Recognition
begins in utero with an inventory of the tissues of the
developing human. This inventory produces a knowledge of
physiological self that will allow the baby's defense mechanisms
to recognize Non-Self in the shapes of viruses, bacteria, fungi,
etc. These disease-causing agents -- known as pathogens -- can
be recognized by their specific protein codes known as antigens.
The actions that the body can take to prevent the entrance of
pathogens or to destroy them once their presence has been
recognized and communicated are many. To begin with, as human
beings we have species resistance (natural immunity) to some
pathogens that can infect other mammals, plants or animals.
Also, we have mechanical barriers, such as the skin and the
mucus membranes that function to prevent infection so long as
their surfaces of defense are unbroken. Enzymes, such as
gastric juice in the stomach, can have a destructive effect on
pathogens. A tissue response like inflammation works to prevent
the spread of infection: the swelling, the heat, the redness,
all indicate the increase of red and white blood cells in the
area working to contain and destroy the non-self agents.
Finally, we have a very specific defense mechanism known as
resistance or immunity that learns to recognize the presence of
specific foreign substances and thereafter continually acts to
destroy them.
The agents of the immune defense mechanism that operate in
response to viral attack are natural killer cells, lymphocytes,
and macrophages. All have their origin in the bone marrow and
differentiate from a multi-potential stem cell. The macrophages
evolve by means of myeloid-stem cells to macrohage precursors to
macrophages, taking up posts in the skin, spleen, blood, and
lymphatic tissues and fluid. The lymphocytes divide into
B-lineage precursors and T-lineage precursors. The
B-lymphocytes (B for "bone") will mature and travel through the
blood to sites in the lymph nodes, organs, tissue, and fluids
waiting for the cue to proliferate and divide into plasma cells
for immediate immune response and into memory cells for long
term immunity. The T-lymphocytes travel through the blood to
the thymus for further education and differentiation. Released
into the blood and lymph system they have two classes, T-4 and
T-8, based on their recognition codes, and each class has two
kinds of functions. There are: T-4 helper cells that enable
many of the immune response actions to occur; T-4 inducer cells
that activate the differentiation of more T-4 and T-8 cells from
the T cell precursors; T-8 cytotoxic cells that do the actual
destroying of virally infected cells; and T-8 suppressor cells
that kick in several weeks into the infectious process to help
shut down the immune response when it is no longer needed.
The natural killer cells function as the first line of defense,
killing virally infected cells spontaneously without interacting
with the lymphocytes or having to recognize the antigen of the
foreign substance. Their activity peaks in one to two days.
The macrophages engulf the virus, break down its protein code
and display its antigen on their cell membranes - with their own
recognition device, a protein molecule encoded by a segment of
the DNA known as major Histiocompatibility Complex (MHC). The
B-lymphocytes function to recognize antigen circulating in the
blood or lymph or displayed on the surface of an infected cell,
and then to produce antibodies, proteins that bind to the
antigens and aid in their destruction and removal. They divide
after recognizing the antigens and produce a clone of
B-lymphocytes with plasma cells secreting the specific antibody
for this antigen and with memory cells encoded with the antibody
formula should the virus try attacking the body again.
To demonstrate how these agents interact, how the immune
response of recognition/communication/action happens, let us
follow a virus as it attacks the body. A virus is unique among
infectious agents in that it is wholly dependent on other cells
(bacterial, plant or animal) for reproduction: it must take over
the DNA of a host cell and transform that cell into a factory
for its own viral DNA message. So, assuming the virus has
invaded the body and taken over a host cell, that virally
infected cell will secrete a protein, interferon, that will
stimulate the activity of the natural killer cells and of the
macrophages. The macrophages will engulf and digest the virus
and display the viral antigen and its own MHC (Class II) on the
macrophage cell membrane. Only by recognizing both of these
codes simultaneously can a T-4 cell activate more events in the
immune response. This recognition by the T-4 cells plus the
secretion of the protein interleukin-1 by the macrophage
stimulates the T-4 cells activity. It will now secrete its own
protein communication, interleukin-2, which will induce T-8
cells that have also recognized the viral antigen and the
macrophage code, MHC (Class I), to proliferate. Some of the new
T-8 cells will be cytotoxic and will destroy virally infected
cells displaying the antigen. Other T-8 cells will be suppressor
cells that act later to shut down the immune response. A T-4
helper cell that has been stimulated by the dual recognition and
the interleukin-2 can also bind with a B-lymphocyte that has
recognized the antigen. The B cell will mature and proliferate
into clones of plasma cells producing immediate antibody and
into clones of memory cells capable of producing antibody years
later. B cells require the contact of the T-4 helper or the
stimulation of the T-4 helper lymphokines (protein signals) to
mature, grow, and differentiate. The interleukin-2 of the T-4
helper cells also bolsters the natural killer cells and the
T-4's gamma-interferon stimulates the virus-engulfing and
antigen-presenting activities of the macrophages. The actions
of the natural killers, the macrophages, the T-8 cytotoxic
cells, and the antibody of the B-plasma cells all contribute to
the destruction of the virus. The T-8 suppressor cells bring
the immune response to a close, and B-memory ells help prevent a
reoccurrence of the viral infection later. However most of the
credit for a successful defense of the body by the immune system
goes to the work of the T-4 helper cells.
The T-4 helper cells are exactly the cells that the AIDS virus
infects. The AIDS virus has been identified as a human
T-lymphotropic virus type III (HTLV-III). It is actually a
retrovirus, meaning that the virus attaches itself to RNA first
and using RNA as an entry, infects the DNA of a host cell. The
host transcribes the viral genes and synthesizes those proteins,
producing new viral cells that spread the infection. The
overwhelming attraction of the HTLVIII retrovirus for the T-4
cells seem to be explained by the finding that the T-4 marker on
the cell membrane, the protein that identifies the cell as
"T-4," serves as the initial attachment point for the virus.
(However it is also likely that macrophages, platelets, and B
cells serve as reservoirs of the virus.)
The consequences of the infection of the T-4 cells by the AIDS
virus are nothing short of the total collapse of the immune
defense mechanisms, leaving the body vulnerable to diseases tat
would ordinarily be rare in the high risk population. With the
onslaught of AIDS, the T-4 cells, which usually constitute
60-80% of the T cells circulating in the blood and lymph system,
become too rare to detect. Without the T-4 cells to recognize
antigen and communicate responses, all the other immune actions
are short circuited. B cells are unable to proliferate and
produce adequate antibody to contain the virus. T-8 cytotoxic
and suppressor cells are similarly incapable of reproducing
enough to meet the challenge. The natural killer cells and the
macrophages receive no additional stimulation and are
overwhelmed by the viral reproductions. The majority of AIDS
victims have succumbed to Kaposi's Sarcoma, a cancer of the
lining of the blood vessels, or to Pneumocystis Carinii, a
protozean pneumonia, or to other diseases usually associated
with immuno-suppression processes following organ transplants or
involving chemotherapy.
Where does the hope lie in all of this?
Amidst the scrambling for research dollars on the part of
scientists and physicians; amidst the controversy over whether
to fund vaccine research or treatment research; amidst the cries
for testing the world for HTLV-III, firing all AIDS victims,
casting gay and bisexual men and IV drug users beyond the Pale
-- amidst all the fear, there are individuals who are addressing
the issue of AIDS, personally and globally.
William Calderon, a hair stylist in San Francisco, was diagnosed
as having Kaposi's Sarcoma in 1982. After an initial plunge
into depression, he took control of his own recovery. He
combined meditation, EST training, the visualization work of
Carl Simonton, an anti-cancer diet, massive doses of vitamin C,
B12, E, and Calcium, the love and support of friends, and his
own will, his sense of self and self esteem to fight the
disease. He claims to have his cancer in remission and his
appearance, the lack of Kaposi's lesions on his body, backs up
that claim.
The lesson for many of us in William Calderon's experience is
simple but challenging: when you seek total integration as an
organism, as a self you can defeat the fragmentation of
psyche/heart/body and the invasion of the non-self. The body
teaches us the same lesson. When the tissues recognize non-self
organisms the whole body gets behind the effort of the immune
defense system to destroy the pathogens. Think of the resources
-- spiritual, mental, financial, emotional, that could be
rallied to the defeat of AIDS (to the defeat of our fears, our
fragmentation/alienation as a species, our solipsism) if we all
recognized AIDS sufferers as our own T-4 cells, as the part of
our own self most vulnerable to the power of non-self. The
universe is testing us... again... still.
BIBLIOGRAPHY
Andrews, Valerie. "Aids: Our First Planetary Illness." The
Tarrytown Letter (Dec. 1985/Jan 1986), pp. 10-13.
Baker Janet. Everything You Must Know About AIDS. Saratoga,
CA: R&E Publishers, 1983.
Fettner, Ann Guidin, and Check, William A. The Truth About AIDS,
Evolution of an Epidemic. NYC: Holt, Rinehart & Winston, 1984.
Gallin,, John I., MD., and Fanci, Anthony S. MD. (Eds). Aquired
Immune Deficiency Syndrome (AIDS). New York: Raven Press, 1985.
Helquist, Michael. "Alternative Therapies... Do They Offer Any
Real Hope to People with AIDS?" The Advocate: The National Gay
Newsmagazine, Vol. 435 (Dec. 10, 1985) pp. 43-47, p. 127.
Hole, John W. Jr., Human Anatomy and Physiology. Dubuque: Wm.
C. Brown Publishers, 1984.
Lawerence, Jeffrey. "The Immune System in AIDS," Scientific
American, Vol. 253 (Dec. 1985), pp. 84-93.
Marrack, Phillipa and Kappler, John. "The T Cell and Its
Receptor." Scientific American, Vol. 254 (Feb. 1986), pp. 36-45.
Tonegawa, Susumu. "The Molecules of the Immune System,"
Scientific American, Vol. 253 (Oct. 1985), pp. 122-131.
|